Exploring Berlin-Buch
Berlin-Buch, today one of the largest biomedical locations in Germany, is a symbiosis of tradition and modernity where research and medical treatment are closely linked. For more than one hundred years Buch has been making medical history.
At the beginning of the 20th century, five large properties were developed into the largest and, at that time, most modern hospital complex in Europe. They were built according to the plans of the legendary municipal building director Ludwig Hoffmann. Even today, the publicly accessible areas of the former hospitals and nursing homes impress the visitor due to their spacious park areas and pleasantly proportioned buildings, which contain elements reminiscent of the Baroque and Classical period.
You will see a mixture of buildings from different eras on the research campus – from the first laboratory buildings to today’s ultra-modern and architecturally sophisticated buildings. Designed as a park, the green campus is an inviting place for walking. Along the different pathways are many works of art, such as "Two Lighthouses for the MDC" by the artist Olafur Eliasson.
The Schlosskirche, one of the four remaining Baroque churches in Berlin, is located in the center of Buch. As ensemble, the church, castle park and municipal estate represent the early history of Buch.
For those seeking leisure and relaxation, the Buch Forest, which belongs to the Barnim Nature Reserve, offers paths for walking and hiking, biking and horseback riding. These paths run along the former sewage fields, where highland cattle and Konik horses graze year round.
News Buch Berlin
Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...
more ...Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenbu...
more ...OMEICOS Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
Interim data confirms OMT-28's strong safety profile in PMD patients, top-line data expected mid-2025
more ...Events Buch Berlin
05.11.2024, 16:00
Die Zukunft der Hirnkrebstherapie: Fortschritte, Herausforderungen und Visionen
Vortrag in der Reihe: Neue Wege in der Biomedizin - Aktuelle Forschungsthemen des Campus Berlin-Buch
more ...06.11.2024, 13:30
Einladung zur Vorlesung: "Rätselhafte Gehirne - Ursachen von Demenz bei Jung und Alt"
in der Reihe "Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch"
more ...11.11.2024, 09:00
Fachkraft für Molekularbiologie
Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung.
more ...